CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- 4 Planned sale EVP, Chief Business Officer sold 32,800 shares at an average $59.34 ($1,946,220)
- 4 Planned sale EVP CLO & General Counsel sold 89,900 shares at an average $60.03 ($5,396,843)
- 4 Planned sale EVP, Chief Scientific Officer sold 38,909 shares at an average $59.14 ($2,301,264)
- 4 Open-market sale Director sold 16,000 shares at $60.15 ($962,371)
- 4 Planned sale EVP, Chf Clinical Develop Ofcr sold 19,658 shares at an average $60.81 ($1,195,421)
- 4 Other acquisition EVP CLO & General Counsel acquired 331 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 189 shares (other)
- 4 Other acquisition EVP, Chief Development Officer acquired 165 shares (other)
- 4 Other acquisition EVP, Chief Scientific Officer acquired 213 shares (other)
- 4 Other acquisition EVP, Corp and Development Ops acquired 166 shares (other)
- 4 Planned sale Director sold 1,427 shares at $42.53 ($60,687)
- 4 Planned sale EVP, Chief Scientific Officer sold 10,000 shares at $43.98 ($439,776)
- 4 Planned sale Director sold 5,000 shares at an average $41.93 ($209,646)
- 4 Planned sale EVP, Chief Development Officer sold 10,000 shares at $42.86 ($428,593)
- 4 Planned sale EVP, Chf Clinical Develop Ofcr sold 9,549 shares at $42.80 ($408,701)
- 4 Planned sale Chief Executive Officer sold 2,432 shares at $45.00 ($109,440)
- 4 Option exercise Director acquired 4,079 shares (option exercise)
- 4 Option exercise Director acquired 4,079 shares (option exercise)
- 4 Option exercise Director acquired 4,079 shares (option exercise)
- 4 Option exercise Director acquired 4,079 shares (option exercise)
Page 8 of 77 · 1,536 filings